In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Abeona Therapeutics Inc (NASDAQ: ABEO) closed at $6.42 in the last session, up 3.05% from day before closing price of $6.23. In other words, the price has increased by $3.05 from its previous closing price. On the day, 1.28 million shares were traded. ABEO stock price reached its highest trading level at $6.435 during the session, while it also had its lowest trading level at $6.15.
Ratios:
We take a closer look at ABEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 05, 2025, initiated with a Outperform rating and assigned the stock a target price of $16.
On July 03, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
On May 30, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $21.Stifel initiated its Buy rating on May 30, 2024, with a $21 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Alvino Mark sold 8,000 shares for $5.68 per share. The transaction valued at 45,440 led to the insider holds 92,435 shares of the business.
Alvino Mark bought 8,000 shares of ABEO for $45,423 on May 16 ’25. On Mar 31 ’25, another insider, Seshadri Vishwas, who serves as the Chief Executive Officer of the company, sold 25,000 shares for $4.78 each. As a result, the insider received 119,500 and left with 1,355,322 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 328426016 and an Enterprise Value of 206338688.
Stock Price History:
The Beta on a monthly basis for ABEO is 1.53, which has changed by 0.49650347 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, ABEO has reached a high of $7.32, while it has fallen to a 52-week low of $3.93. The 50-Day Moving Average of the stock is 21.73%, while the 200-Day Moving Average is calculated to be 13.95%.
Shares Statistics:
According to the various share statistics, ABEO traded on average about 1.49M shares per day over the past 3-months and 1757460 shares per day over the past 10 days. A total of 48.95M shares are outstanding, with a floating share count of 45.20M. Insiders hold about 11.64% of the company’s shares, while institutions hold 59.05% stake in the company. Shares short for ABEO as of 1745971200 were 5453719 with a Short Ratio of 3.66, compared to 1743379200 on 2211450. Therefore, it implies a Short% of Shares Outstanding of 5453719 and a Short% of Float of 12.0.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
